immunomedics inc (IM3:Frankfurt)
Transactions by IMMUNOMEDICS INC (IM3) in the last 6 months
Immunomedics Inc. (NasdaqGM:IMMU) announced a private placement of convertible debt securities and option, warrant or other right to acquire another security for gross proceeds of $1,000,000 on February 8, 2013. The minimum investment accepted from any outside investor is $10,000. As of February 20, 2013, the company has received $445,000 from nine investors. The proceeds include proceeds from the cancellation of indebtedness of the issuer.
| Recently Viewed | |||
| IM3:GR | €2.52 EUR | +0.034 |  |
| Company | Last | Change |
| Arqule Inc | $2.73 USD | -0.02 |
| Cell Therapeutics Inc | $1.24 USD | +0.02 |
| Curis Inc | $3.83 USD | +0.05 |
| MELA Sciences Inc | $1.10 USD | -0.01 |
| Navidea Biopharmaceuticals Inc | $2.44 USD | -0.06 |
| View Industry Companies | ||
Industry Analysis
IM3
Industry Average
| Valuation | IM3 | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 56.2x |
|
| Price/Book | 6.2x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 49.1x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact IMMUNOMEDICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
